REPL 241220 5.00C (REPL241220C5000) Stock Options, News & Quotes

US OptionsDetailed Quotes

REPL241220C5000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 22 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Replimune REPL +35% BLA Submission; Omeros OMER +41% BLA Update
BioPharmCatalystNov 22 19:00 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
BenzingaNov 22 16:06 ET
Friday Market Climbs | Wall Street Today
Kevin TraversNov 22 16:03 ET
Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday
BenzingaNov 22 10:59 ET
Dow Jumps 300 Points; Gap Posts Upbeat Earnings
BenzingaNov 22 10:23 ET
Replimune Climbs After Updates on Lead Drug
Seeking AlphaNov 22 08:31 ET

Comments

Kevin Travers

Yesterday 05:03

Columns Friday Market Climbs | Wall Street Today

The market climbed Friday after a week of waiting and reacting to Nvidia earnings and Bitcoin's all-time highs.
The market overall advanced Friday. Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +0.35%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 0.97%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.16%.
MACRO
In macroeconomics, S&P Global released its composite and service PMI. Composite came in at a two-year high, 55.3...

Weekly Buzz

Kevin Travers

Yesterday 00:06

Columns Market Climbs, Bitcoin Close to $100k | Live Stock

Good morning, traders. Happy Friday, November 22nd. Without the news and animal spirits moving markets, you will not make it through today. My name is Kevin Travers, and the S&P 500 and market climbed this morning, here is what's moving:
$Super Micro Computer (SMCI.US)$ climbed 15%, after earlier this week, the firm said it submitted a plan to release its six-month delayed 10k with a new auditor, BDO USA, and filed for a time extension to file it...

Bitcoin climbs closer to $100,000: How high will it go?

Jaguar8

Nov 22 08:40

😍😍😍

$Replimune (REPL.US)$

Jaguar8

Nov 21 22:29

On watchlist. Reason: Breakthrough Therapy Designation + Biologics License Application in Accelerated pathway for Melanoma. News after hours

$Replimune (REPL.US)$

Trytosaveabit

Nov 21 15:09

News

$Replimune (REPL.US)$ Reuters· 3 mins ago
Replimune Receives Breakthrough Therapy Designation for Rp1 and Submits Rp1 Biologics License Application to the FDA Under the Accelerated Approval Pathway